中等密度脂蛋白和动脉壁内心-中间厚度的进展
1Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033, USA.
Circulation
|April 15, 1997
概括
动脉样硬化进展与中密度脂蛋白 (IDL) 有关. IDL通常包括在LDL胆固醇测量中,在动脉疾病的进展中起着重要作用.
科学领域:
- 心血管研究研究心血管研究
- 脂质代谢 脂质代谢是什么
- 动脉样硬化研究 研究动脉样硬化
背景情况:
- 低密度脂蛋白胆固醇 (LDL-C) 是已知的动脉样硬化风险因素.
- 传统的LDL-C测量包括中密度脂蛋白 (IDL).
- IDL在动脉样硬化进展中的具体作用尚不清楚.
研究的目的:
- 调查血脂蛋白子类与亚临床动脉动脉样硬化的进展之间的关联.
- 澄清IDL对动脉样硬化发展的独立贡献.
主要方法:
- 监测性动脉样硬化回归研究 (MARS) 是一项随机,双盲,安慰剂控制的试验.
- 脂蛋白子类 (LDL,IDL,VLDL,HDL) 在188名受试者中使用分析超离心法量化.
- 动脉内心介质厚度的进展通过高分辨率B模式超声波测定.
主要成果:
- IDL水平与动脉内心介质厚度 (r=.21,P<.005) 的进展有显著的关联.
- 在这项研究中,非常低密度脂蛋白 (VLDL) 和LDL水平与动脉样硬化进展没有显著的关联.
- 这表明IDL是动脉样硬化进展的关键决定因素.
结论:
- 富含三糖蛋白的脂蛋白,特别是IDL,与动脉样硬化症的进展有关.
- 归因于LDL-C的动脉毒性风险可能部分由IDL分数 (Sf12到20) 解释.
- 这些发现强调了在评估心血管风险时考虑IDL的重要性.
相关概念视频
01:38Inflammation
46.0K
Overview
46.0K
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:26Coronary Artery Disease II: Pathophysiology
1.0K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
01:30Atherosclerosis I: Introduction
2.3K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.3K
01:26Atherosclerosis III: Management
634
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
634
01:30Peripheral Artery Disease I: Introduction
653
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
653